ISSN: 2249-9504
CAS CODEN: IJPCDX

Abstracted and Indexed

open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing
+32 25889658
Google Scholar citation report
Citations : 3566

International Journal of Pharmaceutical, Chemical and Biological Sciences received 3566 citations as per google scholar report

International Journal of Pharmaceutical, Chemical and Biological Sciences peer review process verified at publons

ORAL DELIVERY OF INSULIN USING COMPOSITEPOLYMERIC MICROPARTICLES

Abstract

Author(s): Rajesh Kumar1, DK.Majumdar1*, AK. Panda2 and DP. Pathak3

Composite polymeric human insulin loaded microparticles were prepared using triple emulsion solvent evaporation technique with 1% PVA as a stabilizer and 0.1% w/v hydrophilic chitosan in the external aqueous phase, PLGA in internal organic phase and 4-6% w/v Eudragit in external organic phase. The mean diameter of the microparticles was in the range of 1-6 μm. Higher amount of Eudragit polymer provided the maximum drug encapsulation. IVR profile showed that Eudragit L 100 particles have more initial burst release (19.75%) in1 hr. in and % cumulative release (85.15%) in PBS pH 6.8 than Eudragit S 100 particles showing initial burst release (10.31%) in1 hr.and % cumulative release (74.56%). Eudragit L 100: Eudragit S 100 (1:1) particles at pH 6.8 throughout 12 hr. showed more initial burst release (18.45%) in1 hr.and % cumulative release (84.14%) than Eudragit L 100 : Eudragit S 100 (1:1) particles at pH 6.8 in first 1 hr. and remaining 11 hr. at pH 7.4. Eudragit L 100 : Eudragit S 100 (1:1) particles at pH 7.4 throughout 12 hr. showed less initial burst release (10.66%) in 1 hr. and % cumulative release (78.94%). IR spectra suggest the entrapment of insulin in composite polymeric microparticles. CD spectra suggesting maintenance of secondary structure of insulin. SDS-PAGE confirmed that the structural integrity of the drug was maintained during encapsulation. Stability studies results showed that insulin loaded particles stored at 4?C were more stable than particles stored at 25 ?C and at -20 ?C. In-vitro caco-2 cell line studies show that % viability was more for particles than pure insulin solution. TEER values of caco-2 cell monolayer was found to be more for particles at pH 6.8 than particles at pH 7.4.

Get the App